Tectonic Therapeutic Inc. (TECX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Tectonic Therapeutic Inc.

NASDAQ: TECX · Real-Time Price · USD
16.80
-0.47 (-2.72%)
At close: Sep 05, 2025, 3:59 PM
16.90
0.60%
After-hours: Sep 05, 2025, 07:49 PM EDT

Tectonic Therapeutic Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
1.65M 617K 4.17M 1.4M
Gross Profit
-1.65M -617K -4.17M -1.4M
Operating Income
-58.02M -44.65M -105.43M -118.84M
Interest Income
4.26M 581K 149K n/a
Pretax Income
-57.98M -42.82M -105.89M -119.13M
Net Income
-57.98M -42.82M -105.89M -119.13M
Selling & General & Admin
15.01M 7.68M 33.25M 35.73M
Research & Development
41.36M 36.97M 68.02M 81.72M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
56.37M 44.65M 101.27M 117.44M
Interest Expense
107K 152K 144K 224K
Selling & Marketing Expenses
n/a n/a 26.07M 31.09M
Cost & Expenses
-58.02M 44.65M 32.83M 15.61M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
8.49M 3.69M 3.64M 3.57M
Shares Outstanding (Diluted)
8.49M 3.71M 3.64M 3.57M
EPS (Basic)
-6.83 -11.59 -29.05 -33.36
EPS (Diluted)
-6.83 -11.53 -29.05 -33.36
EBITDA
-56.23M -41.19M -101.42M -117.5M
EBIT
-57.88M -42.67M -105.59M -118.9M
Depreciation & Amortization
1.65M 1.48M 4.17M 1.4M